TCL Archive Long-Term Effect Of One Phase III Trial: Benefit For Thousands Of Patients November 27, 2009
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014
TCL Archive PRI, Fending Off More Giants, Reportedly wins New operations. Support contract at Frederick July 10, 1987
